Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Muthu Kumar Thirunavukkarasu & Ramanathan Karuppasamy. (2022) Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening. Journal of Biomolecular Structure and Dynamics 40:22, pages 12392-12403.
Read now
Read now
Sudheer Kumar Katari, Chiranjeevi Pasala, Ravina Madhulitha Nalamolu, Aparna R. Bitla & Amineni Umamaheswari. (2022) In silico trials to design potent inhibitors against matrilysin (MMP-7). Journal of Biomolecular Structure and Dynamics 40:22, pages 11851-11862.
Read now
Read now
Afnan Hassan & Reem K. Arafa. (2022) On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics. Journal of Biomolecular Structure and Dynamics 40:17, pages 7815-7828.
Read now
Read now
Shafi Mahmud, Ekhtiar Rahman, Zulkar Nain, Mutasim Billah, Sumon Karmakar, Sumon Chandro Mohanto, Gobindo Kumar Paul, Al Amin, Uzzal Kumar Acharjee & Md. Abu Saleh. (2021) Computational discovery of plant-based inhibitors against human carbonic anhydrase IX and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:8, pages 2754-2770.
Read now
Read now
Zulkar Nain, Sifat Bin Sayed, Mohammad Minnatul Karim, Md Ariful Islam & Utpal Kumar Adhikari. (2020) Energy-optimized pharmacophore coupled virtual screening in the discovery of quorum sensing inhibitors of LasR protein of Pseudomonas aeruginosa. Journal of Biomolecular Structure and Dynamics 38:18, pages 5374-5388.
Read now
Read now
Praveen Kumar Guttula, Kirti Agrawal, Pradeep Natarajan & Mukesh Kumar Gupta. (2020) Pharmacophore modeling coupled with scaffold hopping to identify novel and potent ribosomal S6 kinase (RSK2) protein antagonists as anti-cancer agents. Journal of Biomolecular Structure and Dynamics 38:16, pages 4947-4955.
Read now
Read now
Articles from other publishers (13)
Syeda Mobeen Anjum, Katari Sudheer Kumar, Amineni Umamaheswari, Dinesh Lakhanpal, Sandeep Swargam, Khateef Riazunnisa & Thummala Chandrasekhar. (2023) Identification of a natural antagonist for signal transducer and activator of transcription 3 (STAT3) by computational approach. Results in Chemistry 5, pages 100970.
Crossref
Crossref
Pradeep Natarajan, Munikumar Manne, Swetha Kumari Koduru & Teja Sree Bokkasam. (2023) 3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agent. Cancer Treatment and Research Communications 36, pages 100744.
Crossref
Crossref
Rishi Gowtham Racherla, Sudheer Kumar Katari, Alladi Mohan, Umamaheswari Amineni, Manohar Badur, Abhijit Chaudhury, Mudhigeti Nagaraja, Sireesha Kodavala, Meenakshi Kante & Usha Kalawat. (2022) Molecular Characterization and Identification of Potential Inhibitors for ‘E’ Protein of Dengue Virus. Viruses 14:5, pages 940.
Crossref
Crossref
Pedro Cruz-Vicente, Luís A. Passarinha, Samuel Silvestre & Eugenia Gallardo. (2021) Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules 26:8, pages 2193.
Crossref
Crossref
R. Shylaja, C. Loganathan, S. Kabilan, T. Vijayakumar & C. Meganathan. (2021) Synthesis and evaluation of the antagonistic activity of 3-acetyl-2H-benzo[g]chromen-2-one against mutant Y537S estrogen receptor alpha via E-Pharmacophore modeling, molecular docking, molecular dynamics, and in-vitro cytotoxicity studies. Journal of Molecular Structure 1224, pages 129289.
Crossref
Crossref
K. N. Vennila, B. Selvakumar, V. Satish, D. Sunny, S. Madhuri & K. P. Elango. (2020) Structure-based design, synthesis, biological evaluation, and molecular docking of novel 10-methoxy dibenzo[b,h][1,6]naphthyridinecarboxamides. Medicinal Chemistry Research 30:1, pages 133-141.
Crossref
Crossref
M. Ajanth Praveen, K.R. Karthika Parvathy, Srimanta Patra, Imran Khan, Pradeep Natarajan & P. Balasubramanian. (2020) Cytotoxic and pharmacokinetic studies of Indian seaweed polysaccharides for formulating raindrop synbiotic candy. International Journal of Biological Macromolecules 154, pages 557-566.
Crossref
Crossref
Sitrarasu Vijaya Prabhu & Sanjeev Kumar Singh. (2019) E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder. Computational Biology and Chemistry 78, pages 414-423.
Crossref
Crossref
Shabir Ahmad GanaiShabir Ahmad Ganai. 2019. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders
65
75
.
Jiqing Cao, Jianwei Hou, Jing Ping & Dongming Cai. (2018) Advances in developing novel therapeutic strategies for Alzheimer’s disease. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Venkatesan Suryanarayanan, Tamilselvam Rajavel, Kasi Pandima Devi & Sanjeev Kumar Singh. (2018) Structure based identification and biological evaluation of novel and potent inhibitors of PCAF catalytic domain. International Journal of Biological Macromolecules 120, pages 823-834.
Crossref
Crossref
Shabir Ahmad Ganai, Ehsaan Abdullah, Romana Rashid & Mohammad Altaf. (2017) Combinatorial In Silico Strategy towards Identifying Potential Hotspots during Inhibition of Structurally Identical HDAC1 and HDAC2 Enzymes for Effective Chemotherapy against Neurological Disorders. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Akshay Rohilla, Garima Khare & Anil K. Tyagi. (2017) Virtual Screening, pharmacophore development and structure based similarity search to identify inhibitors against IdeR, a transcription factor of Mycobacterium tuberculosis. Scientific Reports 7:1.
Crossref
Crossref